Depression

Depression Treatment: Expert Psychiatric Care and Medication Management

Depression is far more than temporary sadness or “feeling down”—it’s a serious medical condition affecting brain chemistry, physical health, and every aspect of daily functioning. Major depressive disorder causes persistent changes in mood, thinking, energy, sleep, appetite, and self-worth that can last months or years without proper treatment. As a board-certified depression psychiatrist with dual MD/PhD credentials in neuroscience, Dr. Gabriella Farkas provides comprehensive evaluation, accurate diagnosis, and evidence-based depression treatment through sophisticated medication management for adults throughout South Carolina, New York, and Virginia via secure telehealth.

Dr. Farkas’s neuroscience background provides deep understanding of the neurobiological mechanisms underlying depression—how dysregulation in brain circuits involving the prefrontal cortex, hippocampus, and amygdala, combined with neurotransmitter imbalances in serotonin, norepinephrine, and dopamine systems, creates the persistent negative mood state characteristic of clinical depression. This scientific foundation enables precise medication selection, offering effective help for depression that addresses root neurobiological causes rather than simply masking symptoms. The National Institute of Mental Health recognizes depression as one of the most common and treatable mental health conditions when individuals receive appropriate professional care.

Understanding Clinical Depression

Everyone feels sad, disappointed, or discouraged at times—these emotions are normal human experiences. Clinical depression, however, involves persistent symptoms lasting weeks, months, or years that significantly impair functioning despite circumstances that might otherwise bring joy or satisfaction. Depression isn’t weakness, lack of willpower, or “just being negative”—it’s a medical illness with neurobiological causes requiring professional treatment.

The Neuroscience of Depression

Depression results from complex interactions among genetic vulnerability, brain chemistry alterations, structural brain changes, and environmental factors. Neuroimaging studies show reduced activity in prefrontal cortex regions controlling mood regulation and executive function, along with hyperactivity in amygdala regions processing negative emotions. Neurotransmitter dysregulation—particularly involving serotonin, norepinephrine, and dopamine—affects mood, motivation, pleasure, sleep, appetite, and cognition. Chronic stress causes changes in the hypothalamic-pituitary-adrenal (HPA) axis affecting cortisol regulation. Neuroplasticity—the brain’s ability to form new connections—becomes impaired, with some studies showing reduced hippocampal volume in chronic depression. These aren’t character defects or failures of positive thinking—they’re medical abnormalities requiring professional depression treatment.

Types of Depression

Several forms of depression exist, each with distinct features affecting treatment approaches:

• Major Depressive Disorder (MDD): The most common form, characterized by persistent depressed mood or loss of interest lasting at least two weeks, accompanied by additional symptoms like sleep changes, appetite changes, fatigue, concentration difficulties, and thoughts of death. Episodes can be single or recurrent.
• Persistent Depressive Disorder (Dysthymia): Chronic, lower-grade depression lasting at least two years. While individual days may not be as severe as major depression, the persistence causes significant cumulative impairment and suffering.
• Treatment-Resistant Depression: Depression that hasn’t adequately responded to at least two appropriate antidepressant trials at therapeutic doses for sufficient duration. Requires specialist evaluation and advanced treatment strategies.
• Depression with Anxious Distress: Major depression accompanied by prominent anxiety symptoms—tension, restlessness, worry, fear of losing control. This subtype may require different medication approaches.
• Depression with Melancholic Features: Severe depression with complete loss of pleasure, worse mood in mornings, early morning awakening, significant psychomotor changes, and profound guilt. Often responds particularly well to medication.
• Depression with Atypical Features: Depression with mood reactivity (mood brightens temporarily with positive events), increased appetite/weight gain, excessive sleep, heavy feelings in limbs, and interpersonal rejection sensitivity. May respond better to certain antidepressant classes.
• Seasonal Affective Disorder (SAD): Recurrent depression occurring during specific seasons, typically fall/winter. Related to reduced sunlight exposure affecting circadian rhythms and neurotransmitter regulation.
• Postpartum Depression: Major depression occurring during pregnancy or within the first year after childbirth. Requires specialized treatment considering breastfeeding and infant care demands.
• Depression in Bipolar Disorder: Depressive episodes occurring in bipolar disorder require different treatment than unipolar depression—antidepressants alone can trigger mania and must be used cautiously with mood stabilizers.

Recognizing Depression Symptoms

Clinical depression involves multiple symptoms occurring together for at least two weeks and representing a change from previous functioning:

Emotional and Cognitive Symptoms

• Persistent Sad, Empty, or Hopeless Mood: Feeling down most of the day, nearly every day—not just occasional sadness but pervasive negative emotional state.
• Anhedonia: Loss of interest or pleasure in activities once enjoyed—hobbies, socializing, sex, food. Nothing feels enjoyable or worth doing.
• Worthlessness or Excessive Guilt: Harsh self-criticism, feeling like a burden, ruminating on past failures, unrealistic guilt about minor issues.
• Difficulty Concentrating: Trouble focusing, making decisions, remembering information. Mind feels foggy or sluggish.
• Recurrent Thoughts of Death or Suicide: Passive wishes to not wake up, active suicidal thoughts, or suicide plans. This is a medical emergency requiring immediate intervention.
• Irritability: Especially common in men with depression—feeling frustrated, angry, or agitated rather than obviously sad.
• Negative Thinking Patterns: Pessimism about future, seeing only negative aspects of situations, catastrophizing minor problems.

Physical Symptoms

• Sleep Disturbance: Insomnia (difficulty falling asleep, staying asleep, or early morning awakening) or hypersomnia (sleeping excessively but never feeling rested).
• Appetite and Weight Changes: Significant weight loss or gain (more than 5% of body weight in a month), or decreased/increased appetite.
• Fatigue and Low Energy: Feeling exhausted even after adequate rest, everything requiring enormous effort, physical heaviness.
• Psychomotor Changes: Either agitation (restlessness, inability to sit still, hand-wringing) or retardation (slowed movements, speech, thinking).
• Physical Pain: Headaches, back pain, muscle aches, gastrointestinal problems without clear medical cause—depression often manifests physically.

Behavioral and Social Impact

• Social withdrawal and isolation
• Neglecting responsibilities at work, school, or home
• Abandoning self-care—hygiene, appearance, health management
• Increased substance use attempting to numb pain
• Crying spells or inability to cry despite wanting to
• Reduced productivity despite working harder
• Avoiding activities, appointments, or social engagements

When to Seek Help for Depression

Many people suffer with depression for months or years before seeking professional depression help, hoping it will resolve on its own or feeling shame about needing assistance. Consider consulting a depression psychiatrist if you experience:

• Persistent Symptoms: Depressed mood or loss of interest lasting more than two weeks, especially if worsening or showing no signs of improvement.
• Significant Functional Impairment: Depression interfering with work performance, relationships, parenting, self-care, or other important life domains despite efforts to push through.
• Suicidal Thoughts: Any thoughts of death, wishing you were dead, or active suicidal ideation require immediate professional evaluation. If you’re in crisis, call 988 Suicide & Crisis Lifeline or go to your nearest emergency room.
• Previous Depression Returning: History of depression with current recurrence of symptoms. Depression often recurs, and early intervention prevents full relapse.
• Treatment Hasn’t Worked: You’ve tried antidepressants, therapy, or self-help strategies without adequate relief. Treatment-resistant depression requires specialist evaluation and sophisticated approaches.
• Can’t Identify a Cause: Feeling depressed despite having “everything”—good job, supportive relationships, comfortable life. Depression doesn’t require external justification; neurobiological factors can cause depression regardless of circumstances.
• Physical Symptoms Without Medical Explanation: Chronic pain, fatigue, or other physical complaints that medical evaluation hasn’t explained may represent somatic manifestations of depression.
• Substance Use Increasing: Using alcohol, cannabis, or other substances to cope with low mood—a pattern that worsens depression while creating additional problems.
• Loved Ones Are Concerned: When family or friends express worry about changes in your mood, behavior, or functioning, their outside perspective may recognize what you’ve normalized.
• Life Transitions Triggering Depression: Retirement, empty nest, relocation, job loss, relationship changes, or medical diagnoses triggering depressive symptoms that interfere with adjustment.

Diagnostic Process for Depression

Accurate diagnosis of depression requires comprehensive psychiatric evaluation distinguishing clinical depression from normal sadness, identifying depression subtypes, and recognizing comorbid conditions. Dr. Farkas’s diagnostic process ensures precision:

Comprehensive Clinical Evaluation (30-60 minutes)

Your initial assessment includes detailed exploration of depressive symptoms—their nature, severity, duration, and impact on functioning. Dr. Farkas gathers information about onset and course of symptoms, previous depressive episodes and treatments, family psychiatric history (depression has genetic components), medical conditions and medications, substance use, trauma history, current life stressors and supports, sleep patterns and appetite changes, and suicidal thoughts or self-harm history. This thorough evaluation enables accurate diagnosis and individualized treatment planning.

Validated Depression Rating Scales

Dr. Farkas uses standardized depression assessment instruments measuring symptom severity and functional impairment. Tools like the PHQ-9 or other validated scales quantify depression levels objectively, establish baseline severity, and provide metrics for tracking treatment response over time. This measurement-based approach increases diagnostic accuracy and enables data-driven treatment decisions rather than relying solely on subjective impressions.

Medical Rule-Outs

Several medical conditions can cause or contribute to depressive symptoms. Dr. Farkas evaluates for thyroid disorders (particularly hypothyroidism), vitamin deficiencies (B12, vitamin D), anemia, chronic medical conditions (diabetes, heart disease, autoimmune disorders), neurological conditions, medication side effects, hormonal changes (menopause, testosterone deficiency), and sleep disorders. Coordination with your primary care physician for appropriate medical testing may be recommended when indicated to ensure comprehensive evaluation.

Differential Diagnosis

Distinguishing major depression from conditions with overlapping symptoms requires expertise. Dr. Farkas carefully evaluates for bipolar disorder (depression may be the presenting episode; history of mania/hypomania changes treatment), adjustment disorder (depressive symptoms following identifiable stressor that may resolve without long-term treatment), grief (normal bereavement versus complicated grief versus major depression), persistent depressive disorder versus major depression, depression secondary to medical conditions or substances, and personality disorders with depressive features. Her research center training and diagnostic expertise enable accurate differentiation.

Comorbidity Assessment

Depression frequently coexists with anxiety disorders, ADHD, eating disorders, substance use issues, PTSD, or chronic pain conditions. Identifying all relevant diagnoses ensures comprehensive depression treatment addressing all factors affecting your mental health and functioning.

Evidence-Based Depression Treatment Through Medication Management

Effective depression treatment can include medication, psychotherapy, or both. Research shows that for moderate to severe depression, combining medication and therapy often produces the best outcomes. Dr. Farkas specializes in medication management—the psychiatric component of treatment. Many patients benefit from combining her medication expertise with separate therapy from psychologists or counselors who provide cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), or other evidence-based psychotherapy approaches.

Why Medication for Depression?

Antidepressant medications work by correcting neurobiological dysregulation in brain chemistry and neural circuits underlying depression. When properly prescribed and monitored, depression treatment medications can significantly reduce symptoms, restore functioning, and improve quality of life. For moderate to severe depression, particularly when causing significant impairment or suicidal ideation, medication is often necessary to achieve adequate symptom control. The Substance Abuse and Mental Health Services Administration provides resources and support for individuals seeking help with depression and other mental health conditions.

First-Line Antidepressants: SSRIs and SNRIs

Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) represent first-line pharmacological treatment for depression due to their effectiveness, safety profile, and tolerability:

SSRIs: These medications increase serotonin availability in the brain by blocking its reuptake, gradually reducing depressive symptoms over several weeks. SSRIs effectively treat major depression, persistent depressive disorder, and depression with anxiety. They require daily dosing and don’t work immediately—full effects typically emerge after 4-6 weeks, though some improvement may appear earlier. SSRIs are generally well-tolerated with manageable side effects and no risk of dependence or addiction.

SNRIs: Similar to SSRIs but affecting both serotonin and norepinephrine, SNRIs effectively treat depression, particularly depression with prominent fatigue, low energy, or chronic pain. They may be especially helpful when SSRIs haven’t been fully effective or when depression coexists with certain physical symptoms.

Dr. Farkas carefully selects specific medications within these classes based on your symptom profile, depression subtype, medical history, potential drug interactions, previous medication responses, side effect concerns, and individual factors. Her neuroscience expertise and pharmacology knowledge enable informed, individualized decisions maximizing likelihood of response while minimizing side effects.

Other Effective Antidepressant Classes

Additional medication options for depression help include:

Bupropion: A unique antidepressant affecting dopamine and norepinephrine rather than serotonin. Particularly helpful for depression with prominent fatigue, low motivation, or concentration difficulties. Also effective for seasonal affective disorder. Unlike SSRIs/SNRIs, doesn’t typically cause sexual side effects or weight gain. Often used when SSRIs cause intolerable side effects or when additional motivation/energy is needed.

Mirtazapine: An atypical antidepressant with different mechanism than SSRIs. Particularly effective for depression with prominent insomnia, anxiety, poor appetite, or weight loss. Sedating effects can help restore sleep, though weight gain is common. Useful when sleep disturbance is a major component of depression.

Tricyclic Antidepressants (TCAs): Older antidepressants that are highly effective but have more side effects than newer medications. Still valuable for treatment-resistant depression or when newer medications haven’t worked. Require careful monitoring but can be excellent options for appropriate patients.

MAOIs (Monoamine Oxidase Inhibitors): The oldest class of antidepressants, requiring dietary restrictions and careful drug interaction monitoring. Reserved for treatment-resistant depression but can be remarkably effective when other medications have failed. Dr. Farkas’s expertise enables safe MAOI management when appropriate.

Augmentation Strategies for Treatment-Resistant Depression

When a single antidepressant provides partial but inadequate response, augmentation—adding a second medication to enhance the first medication’s effectiveness—can be highly successful. Dr. Farkas’s pharmaceutical research experience and advanced training enable sophisticated augmentation strategies including:

• Atypical Antipsychotics: Low doses of certain antipsychotics (aripiprazole, quetiapine, brexiprazole) are FDA-approved for augmenting antidepressants in treatment-resistant depression. Can significantly enhance response when antidepressants alone are insufficient.
• Lithium Augmentation: Adding lithium to antidepressants is one of the best-studied augmentation strategies with strong evidence for effectiveness in treatment-resistant depression.
• Thyroid Hormone (T3): Adding thyroid hormone can enhance antidepressant response even in individuals with normal thyroid function.
• Combination Antidepressants: Combining antidepressants from different classes (e.g., SSRI plus bupropion) can address multiple neurotransmitter systems and improve outcomes.
• Buspirone or Other Adjuncts: Various medications can augment antidepressant effects when standard approaches haven’t achieved adequate response.

Her expertise in treatment-resistant cases helps patients who haven’t improved with conventional approaches finally achieve meaningful relief.

Dr. Farkas’s Approach to Depression Medication Management

Managing antidepressant medications effectively requires more than simply prescribing SSRIs. Dr. Farkas’s approach ensures optimal outcomes:

Individualized Treatment Selection

Multiple effective antidepressants exist, but response varies among individuals. Dr. Farkas considers your specific depression subtype and symptom profile (melancholic, atypical, anxious, etc.), presence of insomnia, fatigue, or appetite changes requiring specific medication effects, comorbid anxiety, ADHD, or other psychiatric conditions, medical conditions and current medications, previous antidepressant trials and responses, side effect concerns and tolerability priorities (sexual function, weight, sedation), suicide risk requiring closer monitoring, and substance use history when selecting initial treatment. Her neuroscience expertise enables informed, personalized decisions.

Setting Realistic Expectations

Understanding antidepressant timelines prevents premature discontinuation. Dr. Farkas explains that most antidepressants require 4-6 weeks for full effect (though some improvement may appear after 2-3 weeks), some temporary worsening of anxiety or activation can occur initially (manageable with dose adjustments), side effects often improve after the first 1-2 weeks as your body adjusts, and treatment typically continues for at least 6-12 months after symptom remission to prevent relapse (longer for recurrent depression). This education ensures patients maintain treatment long enough to experience full benefits rather than stopping prematurely.

Careful Titration and Monitoring

Dr. Farkas starts medications at appropriate initial doses, gradually increases to therapeutic levels while monitoring response and tolerability, uses measurement-based approaches with depression rating scales tracking symptom severity objectively, assesses response at appropriate intervals (typically every 2-4 weeks initially), and continues refining treatment until achieving remission (complete symptom resolution, not just improvement) with minimal adverse effects. This systematic approach maximizes success rates.

Side Effect Management

While antidepressants are generally well-tolerated, side effects can occur. Common issues include initial nausea or gastrointestinal upset (usually temporary), sexual side effects (decreased libido, delayed orgasm, erectile dysfunction), weight changes (gain or loss depending on medication), fatigue or activation (depending on medication and timing), sleep changes (insomnia or sedation), or initial anxiety increase. Dr. Farkas proactively addresses these through dose adjustments, timing modifications (morning versus evening dosing), switching to alternative medications with different side effect profiles, adding medications to counteract specific side effects when appropriate, and lifestyle strategies. Her “no harm” philosophy means not tolerating significant side effects when alternatives exist—though she also educates about balancing tolerability against the serious consequences of inadequately treated depression.

Achieving Remission, Not Just Response

The goal isn’t simply reducing symptoms but achieving complete remission—returning to normal functioning without depressive symptoms. Research shows that achieving full remission (versus partial improvement) significantly reduces relapse risk and improves long-term outcomes. Dr. Farkas continues optimizing treatment until full remission is achieved when possible, rather than settling for “good enough” improvement that leaves residual symptoms.

Relapse Prevention and Long-Term Management

Depression often requires extended treatment to prevent relapse. Dr. Farkas provides continued medication management with regular monitoring even after symptom resolution, appropriate treatment duration (typically 6-12 months minimum after first episode, often longer or indefinitely for recurrent depression), periodic reassessment of treatment necessity and effectiveness, gradual medication discontinuation when appropriate (careful tapering to prevent discontinuation symptoms), and prompt intervention if symptoms begin returning. Her goal is stable, long-term wellness preventing the devastating impact of recurrent depression.

Medication Versus Therapy: Understanding Your Options

Patients often ask whether they need medication, therapy, or both for depression treatment. Understanding options helps you make informed decisions:

What Dr. Farkas Provides: Medication Management

Dr. Farkas is a psychiatrist specializing in psychopharmacology—medical treatment of mental health conditions through medications. She provides comprehensive psychiatric evaluation, accurate diagnosis including depression subtype identification, antidepressant prescription and management, monitoring and optimization, and treatment of complex or treatment-resistant cases. She does not provide psychotherapy (talk therapy, CBT, IPT, or other counseling modalities).

What Therapists Provide: Psychotherapy

Psychologists, licensed professional counselors, and clinical social workers provide evidence-based psychotherapy for depression, including Cognitive Behavioral Therapy (CBT)—highly effective for depression, teaching skills to identify and change negative thought patterns and behaviors; Interpersonal Therapy (IPT)—focusing on relationship patterns and life transitions contributing to depression; Behavioral Activation—systematically increasing engagement in positive activities; and other therapeutic approaches addressing depression’s psychological and behavioral components.

Combining Medication and Therapy

Research shows that for moderate to severe depression, combining medication and psychotherapy often produces better outcomes than either alone, particularly for preventing relapse. Medication reduces symptom severity enabling engagement in therapy, while therapy teaches coping skills and addresses thought patterns maintaining depression. Many of Dr. Farkas’s patients work simultaneously with therapists, with her managing medications while therapists provide CBT or other psychotherapy. She can recommend qualified therapists when appropriate.

Medication Alone

Some patients achieve full remission with medication management alone, particularly when depression is primarily biological rather than situationally driven, when effective therapy isn’t available locally, when time or financial constraints prevent regular therapy, when previous therapy attempts haven’t been helpful, or when depression severity requires medication as foundation before therapy can be effective. Medication-only treatment is a legitimate approach when it effectively resolves symptoms and restores functioning.

Depression and Coexisting Conditions

Depression frequently coexists with other psychiatric and medical conditions:

Depression and Anxiety

Anxiety disorders co-occur with depression in approximately 60% of cases. Sometimes anxiety precedes depression (chronic worry wears you down emotionally); other times depression develops first with anxiety symptoms emerging. Fortunately, SSRIs and SNRIs effectively treat both conditions simultaneously. Dr. Farkas addresses both diagnoses comprehensively when they coexist.

Depression and ADHD

ADHD can cause secondary depression—years of struggling with focus, organization, and underachievement lead to demoralization and hopelessness. Conversely, depression can mimic ADHD symptoms—low motivation and poor concentration appear like inattention. Dr. Farkas’s diagnostic expertise distinguishes primary depression from ADHD-related depression, ensuring appropriate treatment. Often treating ADHD improves depressive symptoms, or both conditions require simultaneous treatment.

Depression and Chronic Pain

Chronic pain and depression frequently coexist, with each worsening the other. Certain antidepressants (particularly SNRIs and tricyclics) treat both depression and chronic pain simultaneously. Dr. Farkas coordinates with pain specialists and primary care physicians ensuring comprehensive care.

Depression and Medical Illness

Medical conditions like heart disease, diabetes, stroke, cancer, and autoimmune disorders significantly increase depression risk. Depression, in turn, worsens medical outcomes and complicates medical treatment adherence. Dr. Farkas coordinates with medical providers ensuring integrated care addressing both mental health and medical needs.

Depression and Substance Use

Many people with untreated depression self-medicate using alcohol or other substances. While providing temporary relief, substance use worsens depression long-term and creates additional problems. Dr. Farkas carefully assesses substance use patterns and addresses both issues (noting that active substance use disorders require specialized addiction treatment she doesn’t provide, but she treats depression in individuals with stable recovery).

Depression Across the Lifespan

Young Adults

Depression often first emerges in late teens or twenties during life transitions—college, first jobs, relationships, independence. Early treatment prevents years of suffering and functional impairment during critical career and relationship formation years. Dr. Farkas helps young adults achieve remission enabling them to build successful lives.

Mid-Life Adults

Career pressures, family responsibilities, aging parents, and financial stress can trigger or worsen depression. High-functioning professionals often hide severe depression behind successful exteriors. Effective treatment enables sustainable success and life satisfaction beyond mere achievement.

Older Adults

Depression in seniors is common but often dismissed as “normal aging”—it’s not. Late-life depression accompanies medical illness, cognitive changes, loss of independence, grief, or retirement transitions. Dr. Farkas’s geriatric psychiatry expertise ensures age-appropriate treatment accounting for medical complexity, medication interactions, and cognitive considerations. Treating depression in older adults improves medical outcomes, cognitive function, and quality of life in retirement years.

Women and Hormonal Influences

Hormonal changes during menstrual cycles, pregnancy, postpartum, and menopause can significantly affect depression. Premenstrual exacerbation of depression is common. Perimenopausal depression affects many women as hormone levels fluctuate. Dr. Farkas understands these influences and adjusts treatment accordingly, including specialized perinatal care when pregnancy or postpartum depression requires careful medication decisions balancing maternal mental health against fetal/infant considerations.

Why Lowcountry Residents Choose Dr. Farkas as Their Depression Psychiatrist

Adults throughout Hilton Head, Bluffton, Beaufort County, and South Carolina seeking expert help for depression choose Dr. Farkas because her qualifications uniquely position her to treat depression optimally:

Neuroscience Expertise: Her PhD in neuroscience provides deep understanding of depression’s neurobiological mechanisms and how antidepressants work at the molecular level—knowledge translating to better treatment decisions and outcomes.

Pharmaceutical Research Background: Direct experience developing psychiatric medications provides insider understanding of medication mechanisms, optimal use, and potential interactions that most psychiatrists never gain.

Treatment-Resistant Expertise: Elite training at an NIH research center and experience with complex cases means she can help when standard treatments haven’t worked, using advanced augmentation strategies and sophisticated medication approaches.

Measurement-Based Care: Using validated depression rating scales rather than subjective impressions leads to more accurate diagnosis, treatment monitoring, and timely adjustments when needed.

Comprehensive Diagnostic Skills: Accurately distinguishing unipolar depression from bipolar depression, identifying depression subtypes, and recognizing comorbid conditions ensures appropriate treatment from the start.

Telehealth Convenience: Receive expert care from home without travel time—particularly valuable when depression makes leaving home, showering, or basic functioning feel overwhelming.

No Judgment, Evidence-Based Approach: Dr. Farkas understands depression is a neurobiological condition, not a character weakness, providing compassionate, scientifically grounded treatment without stigma or dismissiveness.

Getting Started with Depression Treatment

Taking the first step toward professional depression help requires courage when depression tells you nothing will help. The process is straightforward:

1. Contact the Practice: Call or submit an online appointment request. The practice coordinator answers questions about the evaluation process and verifies insurance coverage (Aetna and Cigna in-network; superbills for out-of-network).
2. Complete Intake Forms: Electronic paperwork gathers information about your depressive symptoms, history, and previous treatments before your appointment.
3. Comprehensive Depression Evaluation: Your 30-60 minute video assessment with Dr. Farkas includes detailed clinical interview, standardized depression rating scales, differential diagnosis, and treatment planning.
4. Collaborative Treatment Plan: Dr. Farkas explains your diagnosis, discusses medication options, addresses your concerns, and develops a personalized treatment approach aligned with your preferences and goals.
5. Begin Antidepressant Treatment: Start medication with education about timelines and expectations, careful monitoring, regular follow-up appointments, and optimization to achieve full remission with minimal side effects.
6. Ongoing Support: Continue with regular appointments (frequency based on response and stability), between-session communication for questions or concerns, and long-term partnership focused on achieving and maintaining wellness.

Experience Relief from Depression

If depression has been stealing your joy, energy, motivation, and hope—if you’ve been struggling to function, withdrawing from relationships, or simply going through the motions without really living—effective depression treatment can restore the life depression has taken from you. You don’t have to continue suffering. Accurate diagnosis and evidence-based medication management can significantly reduce depressive symptoms, restore functioning, and help you rediscover pleasure, purpose, and possibility.

Dr. Farkas’s rare combination of neuroscience expertise, pharmaceutical research experience, diagnostic precision, and commitment to achieving remission (not just improvement) provides the level of specialist care that can finally bring lasting relief—even when previous depression treatment attempts have been inadequate. Don’t spend another month in the darkness when expert help exists.

Ready to start feeling better? Contact the practice today to schedule your comprehensive evaluation and begin your journey out of depression toward a brighter, more fulfilling life—one where you can experience joy, connection, energy, and hope again.